Staff Report on Sanofi's Strategic Use of Third Parties To Influence the FDA.

Format:

Book

Government document

Author/Creator:

United States. Congress. Senate. Committee on Finance.

Language:

English

Subjects (All):

Political participation.

Drugs.

Financial disclosure.

Physical Description:

1 online resource (183 pages, digital, PDF file)

monochrome

Place of Publication:

[Place of publication not identified] : [publisher not identified], 2011.

System Details:

System requirements: PDF reader software.

text file

Summary:

Staff report examining Sanofi-Aventis time S.A. alleged misuse of FDA citizen petition process in an attempt to delay approval of a generic version of the pharmaceutical company's blood-thinning medication, Lovenox, citing financial relations between Sanofi-Aventis and three parties who submitted letters to FDA supporting Sanofi-Aventis request to delay generic drug approval.

Appendix (p. 5-177) includes exhibits related to report footnotes.

Notes:

Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Feb. 2013). Reuse except for individual research requires license from ProQuest, LLC.

Other Format:

Microfiche version: United States. Congress. Senate. Committee on Finance. Staff Report on Sanofi's Strategic Use of Third Parties To Influence the FDA. 2011 S362-11

Access Restriction:

Restricted for use by site license.